BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31534114)

  • 1. Association of RAGE rs1800625 Polymorphism and Cancer Risk: A Meta-Analysis of 18 Case-Control Studies.
    Xu Y; Lu Z; Shen N; Wang X
    Med Sci Monit; 2019 Sep; 25():7026-7034. PubMed ID: 31534114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the receptor for advanced glycation end products gene polymorphisms and cancer risk: a systematic review and meta-analysis.
    Zhao DC; Lu HW; Huang ZH
    J BUON; 2015; 20(2):614-24. PubMed ID: 26011358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic predisposition of six well-defined polymorphisms in HMGB1/RAGE pathway to breast cancer in a large Han Chinese population.
    Yue L; Zhang Q; He L; Zhang M; Dong J; Zhao D; Ma H; Pan H; Zheng L
    J Cell Mol Med; 2016 Oct; 20(10):1966-73. PubMed ID: 27241711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The promoter polymorphisms of receptor for advanced glycation end products were associated with the susceptibility and progression of sepsis.
    Shao Y; Shao X; He J; Cai Y; Zhao J; Chen F; Tao H; Yin Z; Tan X; He Y; Lin Y; Li K; Cui L
    Clin Genet; 2017 Apr; 91(4):564-575. PubMed ID: 27172264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased cancer risk associated with the -607C/A polymorphism in interleukin-18 gene promoter: an updated meta-analysis including 12,502 subjects.
    Li X; Ren D; Li Y; Xu J; Liu C; Zhao Y
    J BUON; 2015; 20(3):902-17. PubMed ID: 26214646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH).
    Mehta R; Shaw G; Masschelin P; Felix S; Otgonsuren M; Baranova A; Goodman Z; Younossi Z
    PLoS One; 2018; 13(6):e0199294. PubMed ID: 29928018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between XRCC3 Thr241Met polymorphism and risk of gynecological malignancies: A meta-analysis.
    Yu X; Wang Q; He G; Yu H
    Cancer Genet; 2021 Jun; 254-255():11-17. PubMed ID: 33515810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of
    Kolonaite G; Vilkeviciute A; Kriauciuniene L; Gedvilaite G; Liutkeviciene R
    Ophthalmic Genet; 2021 Dec; 42(6):685-690. PubMed ID: 34338585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of
    Uloza V; Tamauskaite T; Vilkeviciute A; Pasvenskaite A; Liutkevicius V; Liutkeviciene R
    Dis Markers; 2019; 2019():3907232. PubMed ID: 31781300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of RAGE gene Gly82Ser polymorphism with coronary artery disease and ischemic stroke: A systematic review and meta-analysis.
    Ma WQ; Qu QR; Zhao Y; Liu NF
    Medicine (Baltimore); 2016 Dec; 95(49):e5593. PubMed ID: 27930580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
    Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
    BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor for advanced glycation end-product rs1800624 polymorphism contributes to increase breast cancer risk: Evidence from a meta-analysis.
    Zhang W; Deng X; Tang R; Wang H
    Medicine (Baltimore); 2020 Oct; 99(44):e22775. PubMed ID: 33126315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
    Li JF; Zheng EQ; Xie M
    Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAGE gene polymorphism and environmental factor in the risk of oral cancer.
    Su S; Chien M; Lin C; Chen M; Yang S
    J Dent Res; 2015 Mar; 94(3):403-11. PubMed ID: 25582438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of common IL-4 gene polymorphisms with cancer risk: A meta-analysis.
    Jia Y; Xie X; Shi X; Li S
    Mol Med Rep; 2017 Aug; 16(2):1927-1945. PubMed ID: 28656227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
    Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
    Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of RAGE polymorphisms and cancer risk: a meta-analysis of 27 studies.
    Xia W; Xu Y; Mao Q; Dong G; Shi R; Wang J; Zheng Y; Xu L; Jiang F
    Med Oncol; 2015 Feb; 32(2):442. PubMed ID: 25603950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of Cyclooxygenase-2 gene -765G > C (rs20417) and -1195G > A (rs689466) polymorphisms in gastric cancer: A systematic review and meta-analysis.
    Luo MX; Long BB; Li F; Zhang C; Pan MT; Huang YQ; Chen B
    Gene; 2019 Feb; 685():125-135. PubMed ID: 30391440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FASL rs763110 polymorphism contributes to cancer risk: an updated meta-analysis involving 43,295 subjects.
    Xu L; Zhou X; Jiang F; Qiu MT; Zhang Z; Yin R; Xu L
    PLoS One; 2013; 8(9):e74543. PubMed ID: 24086353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of CYP1A1 Polymorphisms on Susceptibility to Chronic Obstructive Pulmonary Disease: A Meta-Analysis.
    Wang CD; Chen N; Huang L; Wang JR; Chen ZY; Jiang YM; He YZ; Ji YL
    Biomed Res Int; 2015; 2015():942958. PubMed ID: 26425562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.